Xu Di

1.7k total citations
25 papers, 1.4k citations indexed

About

Xu Di is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Xu Di has authored 25 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Oncology and 8 papers in Epidemiology. Recurrent topics in Xu Di's work include Autophagy in Disease and Therapy (8 papers), Cell death mechanisms and regulation (7 papers) and Telomeres, Telomerase, and Senescence (6 papers). Xu Di is often cited by papers focused on Autophagy in Disease and Therapy (8 papers), Cell death mechanisms and regulation (7 papers) and Telomeres, Telomerase, and Senescence (6 papers). Xu Di collaborates with scholars based in United States, China and Canada. Xu Di's co-authors include David A. Gewirtz, Lynne W. Elmore, Shawn E. Holt, Molly L. Bristol, Irene Newsham, Robert P. C. Shiu, Patricia A. McChesney, Colleen Jackson‐Cook, Catherine Rehder and Scott C. Henderson and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biomaterials.

In The Last Decade

Xu Di

25 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xu Di United States 19 790 378 336 315 216 25 1.4k
Zhirong Shen China 16 853 1.1× 327 0.9× 192 0.6× 70 0.2× 203 0.9× 37 1.3k
Jayshree L. Hirpara Singapore 16 746 0.9× 207 0.5× 204 0.6× 85 0.3× 257 1.2× 28 1.1k
Kyoungsub Song United States 24 875 1.1× 453 1.2× 209 0.6× 104 0.3× 660 3.1× 48 1.7k
Gong-Kan Feng China 25 1.0k 1.3× 476 1.3× 391 1.2× 64 0.2× 365 1.7× 39 1.8k
Weihua Qiu China 24 738 0.9× 206 0.5× 585 1.7× 72 0.2× 307 1.4× 73 1.7k
Kyung Song United States 22 1.1k 1.4× 164 0.4× 341 1.0× 81 0.3× 280 1.3× 50 1.6k
José Manuel Rodríguez-Vargas Spain 17 900 1.1× 299 0.8× 751 2.2× 68 0.2× 163 0.8× 19 1.5k
Yi Luo China 24 895 1.1× 147 0.4× 273 0.8× 171 0.5× 499 2.3× 75 1.7k
Olesya Vakhrusheva Germany 13 550 0.7× 391 1.0× 164 0.5× 267 0.8× 165 0.8× 24 1.2k

Countries citing papers authored by Xu Di

Since Specialization
Citations

This map shows the geographic impact of Xu Di's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Di with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Di more than expected).

Fields of papers citing papers by Xu Di

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu Di. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Di. The network helps show where Xu Di may publish in the future.

Co-authorship network of co-authors of Xu Di

This figure shows the co-authorship network connecting the top 25 collaborators of Xu Di. A scholar is included among the top collaborators of Xu Di based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Di. Xu Di is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cai, De, et al.. (2025). Precision prognostication in neuroblastomas via clinically validated E2F activity signatures. Frontiers in Immunology. 16. 1612667–1612667. 1 indexed citations
4.
Tang, Bufu, et al.. (2017). MicroRNA-29a regulates lipopolysaccharide (LPS)-induced inflammatory responses in murine macrophages through the Akt1/ NF-κB pathway. Experimental Cell Research. 360(2). 74–80. 44 indexed citations
5.
Bozza, William P., et al.. (2014). The Use of a Stably Expressed FRET Biosensor for Determining the Potency of Cancer Drugs. PLoS ONE. 9(9). e107010–e107010. 8 indexed citations
6.
Sharma, Khushboo, Rachel W. Goehe, Xu Di, et al.. (2014). A novel cytostatic form of autophagy in sensitization of non-small cell lung cancer cells to radiation by vitamin D and the vitamin D analog, EB 1089. Autophagy. 10(12). 2346–2361. 83 indexed citations
7.
Chen, Junjie, William P. Bozza, Xu Di, et al.. (2014). H-Ras regulation of TRAIL death receptor mediated apoptosis. Oncotarget. 5(13). 5125–5137. 18 indexed citations
8.
Alotaibi, Moureq R., Xu Di, Matthew J. Beckman, et al.. (2013). Stilbene 5c, a microtubule poison with vascular disrupting properties that induces multiple modes of growth arrest and cell death. Biochemical Pharmacology. 86(12). 1688–1698. 7 indexed citations
9.
Goehe, Rachel W., Xu Di, Khushboo Sharma, et al.. (2012). The Autophagy-Senescence Connection in Chemotherapy: Must Tumor Cells (Self) Eat Before They Sleep?. Journal of Pharmacology and Experimental Therapeutics. 343(3). 763–778. 103 indexed citations
10.
Bristol, Molly L., Xu Di, Matthew J. Beckman, et al.. (2012). Dual functions of autophagy in the response of breast tumor cells to radiation. Autophagy. 8(5). 739–753. 113 indexed citations
11.
Nguyen, Tuyen T. L., Xu Di, John T. Gupton, et al.. (2012). Autophagy, cell death and sustained senescence arrest in B16/F10 melanoma cells and HCT-116 colon carcinoma cells in response to the novel microtubule poison, JG-03-14. Cancer Chemotherapy and Pharmacology. 71(2). 441–455. 26 indexed citations
12.
Chen, Mengfei, He Zhang, Jie Wu, et al.. (2012). Promotion of the induction of cell pluripotency through metabolic remodeling by thyroid hormone triiodothyronine-activated PI3K/AKT signal pathway. Biomaterials. 33(22). 5514–5523. 33 indexed citations
13.
Chen, Junjie, Hui Shen, Leslie A. Rivera Rosado, et al.. (2012). Mislocalization of death receptors correlates with cellular resistance to their cognate ligands in human breast cancer cells. Oncotarget. 3(8). 833–842. 44 indexed citations
14.
Bristol, Molly L., et al.. (2011). A Switch Between Cytoprotective and Cytotoxic Autophagy in the Radiosensitization of Breast Tumor Cells by Chloroquine and Vitamin D. Hormones and Cancer. 2(5). 272–285. 96 indexed citations
15.
Bristol, Molly L., Xu Di, & David A. Gewirtz. (2011). Abstract 2663: Dual cytoprotective and cytotoxic functions of autophagy in the response ofbreast tumor cells to radiation and in radiosensitization by vitamin D3. Cancer Research. 71(8_Supplement). 2663–2663. 2 indexed citations
16.
Di, Xu, Chris Gennings, Harry D. Bear, et al.. (2010). Influence of the phosphodiesterase-5 inhibitor, sildenafil, on sensitivity to chemotherapy in breast tumor cells. Breast Cancer Research and Treatment. 124(2). 349–360. 58 indexed citations
17.
Di, Xu, Robert P. C. Shiu, Irene Newsham, & David A. Gewirtz. (2009). Apoptosis, autophagy, accelerated senescence and reactive oxygen in the response of human breast tumor cells to Adriamycin. Biochemical Pharmacology. 77(7). 1139–1150. 68 indexed citations
18.
Di, Xu, Ricardo Bellott, Jacques Robert, et al.. (2008). A chemotherapy-associated senescence bystander effect in breast cancer cells. Cancer Biology & Therapy. 7(6). 864–872. 44 indexed citations
19.
Walker, Teneille, et al.. (2004). Influence of p53 and caspase 3 activity on cell death and senescence in response to methotrexate in the breast tumor cell. Biochemical Pharmacology. 68(9). 1699–1708. 41 indexed citations
20.
Elmore, Lynne W., Catherine Rehder, Xu Di, et al.. (2002). Adriamycin-induced Senescence in Breast Tumor Cells Involves Functional p53 and Telomere Dysfunction. Journal of Biological Chemistry. 277(38). 35509–35515. 207 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026